Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc. Newsfile - Thu Dec 22, 2022

Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets and channels to create a pro-forma Combined Company with...

LABS.TO : 0.0850 (+6.25%)
VIVO.TO : 0.0250 (unch)
VVCIF : 0.0179 (-5.29%)
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc. Newswire.ca - Thu Dec 22, 2022

Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets and...

LABS.TO : 0.0850 (+6.25%)
MEDIF : 0.0620 (+1.64%)
VIVO.TO : 0.0250 (unch)
VVCIF : 0.0179 (-5.29%)
MediPharm Labs Receives Award for CBD Brand of the Year PR Newswire - Thu Dec 8, 2022

/PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

LABS.TO : 0.0850 (+6.25%)
MEDIF : 0.0620 (+1.64%)
MediPharm Labs Receives Award for CBD Brand of the Year Newswire.ca - Thu Dec 8, 2022

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based...

MEDIF : 0.0620 (+1.64%)
LABS.TO : 0.0850 (+6.25%)
MediPharm Labs Reports Third Quarter Results Newswire.ca - Mon Nov 14, 2022

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0620 (+1.64%)
LABS.TO : 0.0850 (+6.25%)
MediPharm Labs Sets Date to Report Third Quarter 2022 Financial Results Newswire.ca - Wed Nov 9, 2022

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company") a pharmaceutical company specialized in precision-based...

LABS.TO : 0.0850 (+6.25%)
MEDIF : 0.0620 (+1.64%)
Greenway Cannabis Launches in Quebec Newswire.ca - Mon Nov 7, 2022

/CNW/ - Greenway Greenhouse Cannabis Corporation (CSE: GWAY) ("Greenway Greenhouse" or the "Company") a cultivator of high-quality greenhouse cannabis for the...

GWAY.CN : 0.3050 (+5.17%)
MEDIF : 0.0620 (+1.64%)
LABS.TO : 0.0850 (+6.25%)
Stocks in play: MediPharm Labs Corp Baystreet - Fri Oct 7, 2022

Announces the completed sale of MediPharm Labs Australia Pty, a fully owned subsidiary of the Company, ...

LABS.TO : 0.0850 (+6.25%)
Stocks in play: MediPharm Labs Corp. Baystreet - Fri Oct 7, 2022

Completed the sale of MediPharm Labs Australia Pty, a fully owned subsidiary of the Company, for a value ...

LABS.TO : 0.0850 (+6.25%)
MediPharm Labs Completes Sale of Australian Facility for Proceeds of $7,250,000 AUD PR Newswire - Fri Oct 7, 2022

/PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

LABS.TO : 0.0850 (+6.25%)
MEDIF : 0.0620 (+1.64%)

Barchart Exclusives

2 Reasons Foot Locker Is a Retailer to Watch in 2023 Barchart - Wed Feb 1, 1:33PM CST
Credit Suisse analyst Michael Binetti upgraded Foot Locker stock on Wednesday from Neutral to Outperform. More importantly, the analyst raised his target price by more than 60% to $62, 38% higher than where it’s currently trading.    Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot